A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19
Adeleh Sahebnasagh, Mojataba Mojtahedzadeh, Farhad Najmeddin, Atabak Najafi, Mohammadreza Safdari, Hassan Rezai Ghaleno, Solomon Habtemariam, Ioana Berindan‐Neagoe, Seyed Mohammad Nabavi
Topics & Concepts
ARDSErythropoietinCytokine stormMedicineProinflammatory cytokineDiffuse alveolar damageImmunologyPathogenesisLungCoronavirus disease 2019 (COVID-19)InflammationDiseaseAcute respiratory distressInternal medicineInfectious disease (medical specialty)Erythropoietin and Anemia TreatmentCOVID-19 Clinical Research StudiesErythrocyte Function and Pathophysiology